Drug Profile
Metronidazole foam
Alternative Names: Metronidazole foam - FoamixLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Foamix
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Rosacea
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
- 08 Nov 2010 Discontinued - Preclinical for Rosacea in Israel (Topical)
- 02 Sep 2005 Metronidazole foam is available for licensing (http://www.foamix.co.il)